Im vergangenen Jahr erzielte Takeda Pharmaceutical Co Ltd für sein leistungsstärkstes Segment, Pharmaceutical Business, Einnahmen von 4.42T USD. Die Region United States leistete den größten Beitrag mit 2.16T USD im letzten Jahr. Im letzten Quartal berichtete Takeda Pharmaceutical Co Ltd über Einnahmen in Höhe von 386.10B USD für den Zeitraum bis zum 2026-06-30, die aus dem leistungsstärksten Segment, Gastrointestinal diseases, stammten. United States trug mit 568.90B USD den höchsten Umsatz bei.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Pharmaceutical Business

Intellectual Property And Service Revenue

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Pharmaceutical Business

4.42T(98.17%)

4.50T(98.13%)

4.16T(97.65%)

3.92T(97.39%)

3.30T(92.34%)

3.11T(97.11%)

3.20T(97.36%)

2.03T(96.62%)

1.69T(95.67%)

Intellectual Property And Service Revenue

82.61B(1.83%)

85.58B(1.87%)

100.11B(2.35%)

105.20B(2.61%)

273.28B(7.66%)

92.44B(2.89%)

87.04B(2.64%)

70.95B(3.38%)

76.69B(4.33%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

United States

Europe And Canada (Country)

Japan

Latin America

China (Country)

Others

Asia

Russia/CIS

United States

Europe

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

United States

2.16T(48.05%)

--(--)

598.34B(33.79%)

520.16B(30.03%)

514.42B(28.46%)

426.13B(23.97%)

374.53B(22.14%)

Europe And Canada (Country)

1.15T(25.44%)

1.06T(23.03%)

966.84B(22.68%)

842.67B(20.92%)

739.17B(20.71%)

666.18B(20.83%)

645.53B(19.61%)

405.64B(19.34%)

313.72B(17.72%)

279.69B(16.15%)

309.27B(17.11%)

325.29B(18.30%)

--(--)

Japan

433.11B(9.61%)

418.46B(9.13%)

451.39B(10.59%)

512.04B(12.71%)

658.98B(18.46%)

559.75B(17.50%)

592.79B(18.01%)

571.02B(27.23%)

580.35B(32.78%)

655.34B(37.84%)

688.09B(38.07%)

712.81B(40.09%)

733.88B(43.38%)

Latin America

254.13B(5.64%)

235.85B(5.15%)

198.10B(4.65%)

160.38B(3.98%)

128.47B(3.60%)

121.64B(3.80%)

143.46B(4.36%)

88.11B(4.20%)

75.66B(4.27%)

72.52B(4.19%)

68.39B(3.78%)

85.37B(4.80%)

81.25B(4.80%)

China (Country)

195.14B(4.33%)

191.74B(4.19%)

--(--)

Others

133.89B(2.97%)

128.85B(2.81%)

117.91B(2.77%)

95.18B(2.36%)

68.94B(1.93%)

68.52B(2.14%)

71.26B(2.17%)

38.31B(1.83%)

30.19B(1.71%)

33.99B(1.96%)

39.42B(2.18%)

35.49B(2.00%)

29.54B(1.75%)

Asia

98.67B(2.19%)

99.39B(2.17%)

261.22B(6.13%)

225.01B(5.59%)

196.96B(5.52%)

156.24B(4.89%)

165.40B(5.03%)

105.41B(5.03%)

104.03B(5.88%)

112.80B(6.51%)

125.96B(6.97%)

111.41B(6.27%)

85.37B(5.05%)

Russia/CIS

79.72B(1.77%)

72.36B(1.58%)

72.59B(1.70%)

88.43B(2.20%)

62.06B(1.74%)

57.56B(1.80%)

76.83B(2.33%)

59.74B(2.85%)

68.24B(3.85%)

57.55B(3.32%)

61.82B(3.42%)

81.32B(4.57%)

89.57B(5.29%)

United States

--(--)

2.38T(51.94%)

2.20T(51.50%)

2.10T(52.24%)

1.71T(48.04%)

1.57T(49.03%)

1.60T(48.49%)

828.99B(39.53%)

--(--)

Europe

--(--)

297.55B(17.59%)